Hallahan; Dennis E.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hallahan; Dennis E..The latest application filed is for "antibodies to tip-1 and grp78".
Company Profile
1.37.35
- Hallahan; Dennis E. - St. Louis MO
- Hallahan; Dennis E. - Nashville TN US
- Hallahan; Dennis E. - Park Ridge IL
- Hallahan; Dennis E. - Chicago IL
Patent Activity
| Patent | Date |
|---|---|
| Compositions targeting radiation-induced molecules and methods of use thereof Grant 10,449,261 - Hallahan Oc | 2019-10-22 |
| Antibodies to GRP78 Grant 10,259,884 - Hallahan , et al. | 2019-04-16 |
| Ligands to radiation-induced molecules Grant 10,086,073 - Hallahan , et al. October 2, 2 | 2018-10-02 |
| Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv Grant 10,066,008 - Hallahan , et al. September 4, 2 | 2018-09-04 |
| Antibodies To Tip-1 And Grp78 App 20170298142 - Hallahan; Dennis E. ; et al. | 2017-10-19 |
| Antibodies to TIP-1 Grant 9,738,725 - Hallahan , et al. August 22, 2 | 2017-08-22 |
| Compositions Targeting Radiation-induced Molecules And Methods Of Use Thereof App 20170209603 - Hallahan; Dennis E. | 2017-07-27 |
| Ligands To Radiation-induced Molecules App 20160206736 - Hallahan; Dennis E. ; et al. | 2016-07-21 |
| Monoclonal Antibodies To Human 14-3-3 Epsilon And Human 14-3-3 Epsilon Sv App 20160194388 - Hallahan; Dennis E. ; et al. | 2016-07-07 |
| Ligands to radiation-induced molecules Grant 9,340,581 - Hallahan , et al. May 17, 2 | 2016-05-17 |
| Phage antibodies to radiation-inducible neoantigens Grant 8,927,288 - Hallahan , et al. January 6, 2 | 2015-01-06 |
| Ligands To Radiation-induced Molecules App 20140369929 - Hallahan; Dennis E. ; et al. | 2014-12-18 |
| Antibodies To Tip-1 And Grp78 App 20140316186 - Hallahan; Dennis E. ; et al. | 2014-10-23 |
| Use of GSK3 inhibitors in combination with radiation therapies Grant 8,771,754 - Hallahan July 8, 2 | 2014-07-08 |
| Ligands to radiation-induced molecules Grant 8,765,097 - Hallahan , et al. July 1, 2 | 2014-07-01 |
| Specific inhibition of cPLA.sub.2 enhances the efficacy of radiotherapy Grant 8,740,762 - Hallahan , et al. June 3, 2 | 2014-06-03 |
| Phage Antibodies To Radiation-inducible Neoantigens App 20140088408 - Hallahan; Dennis E. ; et al. | 2014-03-27 |
| Phage antibodies to radiation-inducible neoantigens Grant 8,617,521 - Hallahan , et al. December 31, 2 | 2013-12-31 |
| Ligands To Radiation-induced Molecules App 20130251628 - Hallahan; Dennis E. ; et al. | 2013-09-26 |
| Ligands to radiation-induced molecules Grant 8,388,932 - Hallahan , et al. March 5, 2 | 2013-03-05 |
| Ligands To Radiation-induced Molecules App 20120089017 - Hallahan; Dennis E. | 2012-04-12 |
| Bmx mediated signal transduction in irradiated vascular endothelium Grant 8,129,356 - Hallahan , et al. March 6, 2 | 2012-03-06 |
| Phage Antibodies To Radiation-inducible Neoantigens App 20120041303 - Hallahan; Dennis E. ; et al. | 2012-02-16 |
| Ligands to radiation-induced molecules Grant 8,101,157 - Hallahan January 24, 2 | 2012-01-24 |
| Phage antibodies to radiation-inducible neoantigens Grant 8,012,945 - Hallahan , et al. September 6, 2 | 2011-09-06 |
| Ligands To Radiation-induced Molecules App 20110213293 - Hallahan; Dennis E. ; et al. | 2011-09-01 |
| In vivo panning for ligands to radiation-induced molecules Grant 7,968,675 - Hallahan , et al. June 28, 2 | 2011-06-28 |
| Constitutive gene expression in conjunction with ionizing radiation Grant 7,919,310 - Weichselbaum , et al. April 5, 2 | 2011-04-05 |
| Ligands to radiation-induced molecules Grant 7,906,102 - Hallahan , et al. March 15, 2 | 2011-03-15 |
| X-ray guided drug delivery Grant 7,875,454 - Hallahan January 25, 2 | 2011-01-25 |
| Assessment Of Cancer Susceptibility To Molecular Targeted Therapy By Use Of Recombinant Peptides App 20100135905 - Hallahan; Dennis E. | 2010-06-03 |
| Constitutive gene expression in conjuction with ionizing radiation Grant 7,592,317 - Weichselbaum , et al. September 22, 2 | 2009-09-22 |
| Bmx Mediated Signal Transduction In Irradiated Vascular Endothelium App 20090136487 - HALLAHAN; DENNIS E. ; et al. | 2009-05-28 |
| Use of GSK3 inhibitors in combination with radiation therapies App 20090041863 - Hallahan; Dennis E. | 2009-02-12 |
| Specific Inhibition Of Cpla2 Enhances The Efficacy Of Radiotherapy App 20080262286 - Hallahan; Dennis E. ; et al. | 2008-10-23 |
| In Vivo Panning For Ligands To Radiation-induced Molecules App 20080206130 - Hallahan; Dennis E. ; et al. | 2008-08-28 |
| Phage antibodies to radiation-inducible neoantigens App 20080187488 - Hallahan; Dennis E. ; et al. | 2008-08-07 |
| In vivo panning for ligands to radiation-induced molecules Grant 7,402,392 - Hallahan , et al. July 22, 2 | 2008-07-22 |
| Constitutive Gene Expression In Conjunction With Ionizing Radiation App 20080118471 - Weichselbaum; Ralph R. ; et al. | 2008-05-22 |
| Methods and Compositions for Viral Enhancement of Cell Killing App 20080014175 - Hallahan; Dennis E. ; et al. | 2008-01-17 |
| Phage antibodies to radiation-inducible neoantigens Grant 7,306,925 - Hallahan , et al. December 11, 2 | 2007-12-11 |
| Ligands to radiation-induced molecules App 20070065361 - Hallahan; Dennis E. | 2007-03-22 |
| X-ray guided drug delivery App 20060188442 - Hallahan; Dennis E. | 2006-08-24 |
| X-ray guided drug delivery Grant 7,049,140 - Hallahan May 23, 2 | 2006-05-23 |
| Ligands to radiation-induced molecules App 20060104898 - Hallahan; Dennis E. ; et al. | 2006-05-18 |
| Gene transcription and ionizing radiation: methods and compositions Grant 7,041,653 - Weichselbaum , et al. May 9, 2 | 2006-05-09 |
| Pi3k antagonists as radiosensitizers App 20060084697 - Hallahan; Dennis E. ; et al. | 2006-04-20 |
| Gene transcription and ionizing radiation: methods and compositions App 20060058258 - Weichselbaum; Ralph R. ; et al. | 2006-03-16 |
| Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides App 20060046271 - Hallahan; Dennis E. | 2006-03-02 |
| Methods and compositions for viral enhancement of cell killing App 20050147591 - Hallahan, Dennis E. ; et al. | 2005-07-07 |
| Phage antibodies to radiation-inducible neoantigens App 20040191249 - Hallahan, Dennis E. ; et al. | 2004-09-30 |
| Targeted drug delivery methods App 20030219785 - Hallahan, Dennis E. ; et al. | 2003-11-27 |
| Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system App 20030216337 - Hallahan, Dennis E. | 2003-11-20 |
| Inhibition of VEGF receptor signaling reverses tumor resistance to radiotherapy App 20030181377 - Hallahan, Dennis E. ; et al. | 2003-09-25 |
| Gene transcription and ionizing radiation: methods and compositions Grant 6,605,712 - Weichselbaum , et al. August 12, 2 | 2003-08-12 |
| In vivo panning for ligands to radiation-induced molecules App 20030130190 - Hallahan, Dennis E. ; et al. | 2003-07-10 |
| Gene transcription and ionizing radiation: methods and compositions App 20010006954 - Weichselbaum, Ralph R. ; et al. | 2001-07-05 |
| X-ray guided drug delivery Grant 6,159,443 - Hallahan December 12, 2 | 2000-12-12 |
| Methods and compositions for targeting selectins Grant 5,962,424 - Hallahan , et al. October 5, 1 | 1999-10-05 |
| Control of gene expression by ionizing radiation Grant 5,817,636 - Weichselbaum , et al. October 6, 1 | 1998-10-06 |
| Regulation of x-ray mediated gene expression Grant 5,641,755 - Weichselbaum , et al. June 24, 1 | 1997-06-24 |
| Control of gene expression by ionizing radiation Grant 5,612,318 - Weichselbaum , et al. March 18, 1 | 1997-03-18 |
Company Registrations
| NCAGE Code | 45QY0 | HALLAHAN DENNIS E |
| CAGE Code | 45QY0 | HALLAHAN, DENNIS E |
| DUNS | 606005465 | HALLAHAN, DENNIS E |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 